These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2789717)

  • 41. Immunohistochemical expression of neural tissue markers (neuron-specific enolase, glial fibrillary acidic protein, S100 protein) in ameloblastic fibrodentinoma: a comparative study with ameloblastic fibroma.
    Takeda Y; Sato H; Satoh M; Nakamura SI; Yamamoto H
    Pathol Int; 2000 Aug; 50(8):610-5. PubMed ID: 10972858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pigmented neuroectodermal tumour of infancy: an immunohistochemical study.
    Stirling RW; Powell G; Fletcher CD
    Histopathology; 1988 Apr; 12(4):425-35. PubMed ID: 2453438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical demonstration of neuronal and astrocytic differentiation in retinoblastoma.
    Messmer EP; Font RL; Kirkpatrick JB; Höpping W
    Ophthalmology; 1985 Jan; 92(1):167-73. PubMed ID: 3883281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression.
    Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
    Anticancer Res; 1996; 16(5A):2687-92. PubMed ID: 8917371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
    Woodburn RT; Azzarelli B; Montebello JF; Goss IE
    J Neurooncol; 2001 Mar; 52(1):57-62. PubMed ID: 11451203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuron-associated class III beta-tubulin, tau, and MAP2 in the D-283 Med cell line and in primary explants of human medulloblastoma.
    Vinores SA; Herman MM; Katsetos CD; May EE; Frankfurter A
    Histochem J; 1994 Aug; 26(8):678-85. PubMed ID: 7527016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors.
    Johnson MD; O'Connell MJ; Silberstein H; Korones D
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):532-8. PubMed ID: 23455179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of FLI-1 and analysis of prognostic factors in primitive neuroectodermal tumor].
    Chen LJ; Jia YX; Fan FF; Li XY
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):917-20. PubMed ID: 21223800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glial fibrillary acidic protein in medulloblastomas.
    Kumanishi T; Washiyama K; Watabe K; Sekiguchi K
    Acta Neuropathol; 1985; 67(1-2):1-5. PubMed ID: 4024863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Choroid plexus tumours--an immunohistochemical analysis with review of literature.
    Radotra BD; Joshi K; Kak VK; Banerjee AK
    Indian J Pathol Microbiol; 1994 Jan; 37(1):9-19. PubMed ID: 7522222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A clinicopathological analysis of primitive neuroectodermal tumors of the CNS].
    Zhang Q; Su X; Liang S
    Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):282-5. PubMed ID: 11244998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunophenotype profile of childhood medulloblastomas and supratentorial primitive neuroectodermal tumors using 16 monoclonal antibodies.
    Zeltzer PM; Bodey B; Marlin A; Kemshead J
    Cancer; 1990 Jul; 66(2):273-83. PubMed ID: 2196109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiation in the medulloblastoma. A histological and immunohistochemical study.
    Burger PC; Grahmann FC; Bliestle A; Kleihues P
    Acta Neuropathol; 1987; 73(2):115-23. PubMed ID: 3604579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer.
    Bühren J; Christoph AH; Buslei R; Albrecht S; Wiestler OD; Pietsch T
    J Neuropathol Exp Neurol; 2000 Mar; 59(3):229-40. PubMed ID: 10744061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuron-specific enolase and neurofilament protein as markers of differentiation in medulloblastoma.
    Velasco ME; Ghobrial MW; Ross ER
    Surg Neurol; 1985 Feb; 23(2):177-82. PubMed ID: 3917581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokeratin expression in a congenital multipotential primitive neuroectodermal tumor.
    Zimmer C; Figols J; Patt S; Cervos-Navarro J
    Childs Nerv Syst; 1991 Nov; 7(7):405-9. PubMed ID: 1724412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nerve cell markers in ossifying fibromyxoid tumour of soft parts.
    Shet T; Desai S; Kane S; Vora I
    Indian J Pathol Microbiol; 2001 Apr; 44(2):163-7. PubMed ID: 11883138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The modulation of astrocytic differentiation in cells derived from a medulloblastoma surgical specimen.
    Maria BL; Steck PA; Yung WK; Milici A; Bruner JM; Pathak S; Becker FF
    J Neurooncol; 1989 Nov; 7(4):329-38. PubMed ID: 2555453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.